Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 22 November 1991:
Vol. 254. no. 5035, pp. 1161 - 1167
DOI: 10.1126/science.1957168
Prev | Table of Contents | Next

Articles

Science, Vol 254, Issue 5035, 1161-1167
Copyright © 1991 by American Association for the Advancement of Science

articles

Transgenic models of tumor development

JM Adams and S Cory

Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.

Numerous cancer-prone strains of mice have been created by the introduction of candidate tumor-promoting genes into fertilized eggs. Each transgenic strain is predisposed to develop specific types of tumors, but they usually arise stochastically because of the need for spontaneous mutation of genes that collaborate with the introduced oncogene. These mice are providing insights into the effects of individual oncogenes on cellular proliferation, differentiation, and viability, as well as on oncogene cooperativity. Their predisposed state imposes sensitivity to viral and chemical carcinogenesis, and the mice should prove valuable in tests of potential carcinogens, therapies, and preventive measures.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Modeling Chromosomal Translocations Using Conditional Alleles to Recapitulate Initiating Events in Human Leukemias.
M. N. Lobato, M. Metzler, L. Drynan, A. Forster, R. Pannell, and T. H. Rabbitts (2008)
J Natl Cancer Inst Monographs 2008, 58-63
   Abstract »    Full Text »    PDF »
Mouse modeling in oncologic preclinical and translational research..
B. S. Carver and P. P. Pandolfi (2006)
Clin. Cancer Res. 12, 5305-5311
   Abstract »    Full Text »    PDF »
Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.
G. Qin, R. Kishore, C. M. Dolan, M. Silver, A. Wecker, C. N. Luedemann, T. Thorne, A. Hanley, C. Curry, L. Heyd, et al. (2006)
PNAS 103, 11015-11020
   Abstract »    Full Text »    PDF »
The Myc Target Gene JPO1/CDCA7 Is Frequently Overexpressed in Human Tumors and Has Limited Transforming Activity In vivo.
R. C. Osthus, B. Karim, J. E. Prescott, B. D. Smith, M. McDevitt, D. L. Huso, and C. V. Dang (2005)
Cancer Res. 65, 5620-5627
   Abstract »    Full Text »    PDF »
Hematopoietic Cell Fate and the Initiation of Leukemic Properties in Primitive Primary Human Cells Are Influenced by Ras Activity and Farnesyltransferase Inhibition.
C. Dorrell, K. Takenaka, M. D. Minden, R. G. Hawley, and J. E. Dick (2004)
Mol. Cell. Biol. 24, 6993-7002
   Abstract »    Full Text »    PDF »
Normal Human Fibroblasts Are Resistant to RAS-Induced Senescence.
J. A. Benanti and D. A. Galloway (2004)
Mol. Cell. Biol. 24, 2842-2852
   Abstract »    Full Text »    PDF »
Replication Failure, Genome Instability, and Increased Cancer Susceptibility in Mice with a Point Mutation in the DNA Ligase I Gene.
C. Harrison, A.-M. Ketchen, N. J. Redhead, M. J. O'Sullivan, and D. W. Melton (2002)
Cancer Res. 62, 4065-4074
   Abstract »    Full Text »    PDF »
p53 Is Necessary for the Apoptotic Response Mediated by a Transient Increase of Ras Activity.
P. Ma, M. Magut, X. Chen, and C.-Y. Chen (2002)
Mol. Cell. Biol. 22, 2928-2938
   Abstract »    Full Text »    PDF »
Blocking Oncogenic Ras Signaling for Cancer Therapy.
A. A. Adjei (2001)
J Natl Cancer Inst 93, 1062-1074
   Abstract »    Full Text »    PDF »
Prostate Carcinomas Developing in Transgenic Rats with SV40 T Antigen Expression under Probasin Promoter Control Are Strictly Androgen Dependent.
M. Asamoto, N. Hokaiwado, Y.-M. Cho, S. Takahashi, Y. Ikeda, K. Imaida, and T. Shirai (2001)
Cancer Res. 61, 4693-4700
   Abstract »    Full Text »    PDF »
Metastasizing Neuroblastomas from Taste Buds in Rats Transgenic for the Simian Virus 40 Large T Antigen under Control of the Probasin Gene Promoter.
M. Asamoto, N. Hokaiwado, Y.-M. Cho, Y. Ikeda, S. Takahashi, and T. Shirai (2001)
Toxicol Pathol 29, 363-368
   Abstract »    PDF »
Review Article: Use of Transgenic Animals for Carcinogenicity Testing: Considerations and Implications for Risk Assessment.
D. Gulezian, D. Jacobson-Kram, C. B. Mccullough, H. Olson, L. Recio, D. Robinson, R. Storer, R. Tennant, J. M. Ward, and D. A. Neumann (2000)
Toxicol Pathol 28, 482-499
   Abstract »    PDF »
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease.
J. S. Butel (2000)
Carcinogenesis 21, 405-426
   Abstract »    Full Text »    PDF »
Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.
S. Ogilvy, D. Metcalf, C. G. Print, M. L. Bath, A. W. Harris, and J. M. Adams (1999)
PNAS 96, 14943-14948
   Abstract »    Full Text »    PDF »
Paradoxical Inhibition of c-myc-induced Carcinogenesis by Bcl-2 in Transgenic Mice.
A. d. L. Coste, A. Mignon, M. Fabre, E. Gilbert, A. Porteu, T. V. Dyke, A. Kahn, and C. Perret (1999)
Cancer Res. 59, 5017-5022
   Abstract »    Full Text »    PDF »
Promoter Elements of vav Drive Transgene Expression In Vivo Throughout the Hematopoietic Compartment.
S. Ogilvy, D. Metcalf, L. Gibson, M. L. Bath, A. W. Harris, and J. M. Adams (1999)
Blood 94, 1855-1863
   Abstract »    Full Text »    PDF »
Anticancer Agents Targeting Signaling Molecules and Cancer Cell Environment: Challenges for Drug Development?.
K. A. Gelmon, E. A. Eisenhauer, A. L. Harris, M. J. Ratain, and P. Workman (1999)
J Natl Cancer Inst 91, 1281-1287
   Full Text »    PDF »
Transgene Expression and Repression in Transgenic Rats Bearing the Phosphoenolpyruvate Carboxykinase-Simian Virus 40 T Antigen or the Phosphoenolpyruvate Carboxykinase-Transforming Growth Factor-{alpha} Constructs.
M. J. Haas, Y. P. Dragan, H. Hikita, R. Shimel, K. Takimoto, S. Heath, J. Vaughan, and H. C. Pitot (1999)
Am. J. Pathol. 155, 183-192
   Abstract »    Full Text »    PDF »
Expression of E2A-HLF Chimeric Protein Induced T-Cell Apoptosis, B-Cell Maturation Arrest, and Development of Acute Lymphoblastic Leukemia.
H. Honda, T. Inaba, T. Suzuki, H. Oda, Y. Ebihara, K. Tsuiji, T. Nakahata, T. Ishikawa, Y. Yazaki, and H. Hirai (1999)
Blood 93, 2780-2790
   Abstract »    Full Text »    PDF »
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice.
G. Bergers, K. Javaherian, K. Lo, J. Folkman, and D. Hanahan (1999)
Science 284, 808-812
   Abstract »    Full Text »
Nonrandom Cytogenetic Alterations in Hepatocellular Carcinoma from Transgenic Mice Overexpressing c-Myc and Transforming Growth Factor-{alpha} in the Liver.
L. M. Sargent, X. Zhou, C. L. Keck, N. D. Sanderson, D. B. Zimonjic, N. C. Popescu, and S. S. Thorgeirsson (1999)
Am. J. Pathol. 154, 1047-1055
   Abstract »    Full Text »    PDF »
Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease.
J. S. Butel and J. A. Lednicky (1999)
J Natl Cancer Inst 91, 119a-134a
   Abstract »    Full Text »    PDF »
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism.
C. V. Dang (1999)
Mol. Cell. Biol. 19, 1-11
   Full Text »    PDF »
Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice.
W. Kulwichit, R. H. Edwards, E. M. Davenport, J. F. Baskar, V. Godfrey, and N. Raab-Traub (1998)
PNAS 95, 11963-11968
   Abstract »    Full Text »    PDF »
LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes.
T. H. Rabbitts (1998)
Genes & Dev. 12, 2651-2657
   Full Text »
Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells.
D. S. Pereira, C. Dorrell, C. Y. Ito, O. I. Gan, B. Murdoch, V. N. Rao, J.-P. Zou, E. S. P. Reddy, and J. E. Dick (1998)
PNAS 95, 8239-8244
   Abstract »    Full Text »    PDF »
The Clinical Significance of Fusion Oncogenes in Cancer.
T.H. Rabbitts (1998)
N. Engl. J. Med. 338, 192-194
   Full Text »
Transcription Factors, Normal Myeloid Development, and Leukemia.
D. G. Tenen, R. Hromas, J. D. Licht, and D.-E. Zhang (1997)
Blood 90, 489-519
   Full Text »    PDF »
Insulin-like Growth Factor II Is Focally Up-regulated and Functionally Involved as a Second Signal for Oncogene-induced Tumorigenesis.
P. Naik, G. Christofori, and D. Hanahan (1994)
Cold Spring Harb Symp Quant Biol 59, 459-470
   Abstract »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)